Eluciderm
San Diego, US · Founded 2018 · Delaware corporation
Biotech
Founders & leadership
DD
Daniel Dale HolsworthExecutive Officer, Director
DP
David P. MichalekExecutive Officer
JP
John P. DelgadoExecutive Officer, Director
Reported raises · per SEC filings
Form D private placements▶$2MraisedMay 2022 · 3 investors · PharmaceuticalsRule 506(b)
Officers, directors & promoters on the filing
- John DelgadoDirector
- Daniel HolsworthExecutive Officer, Director
- Joseph MarinoDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$4.3KraisedOct 2021 · 1 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- Daniel Dale HolsworthExecutive Officer, Director
- David P. MichalekExecutive Officer
- John P. DelgadoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $4.3K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.8MraisedOct 2021 · 49 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- John P. DelgadoExecutive Officer, Director
- Daniel Dale HolsworthExecutive Officer, Director
- David P. MichalekExecutive Officer
- Joseph P. MarinoExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.8M
- First sale
- Mar 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.